2019
DOI: 10.1016/j.bbadis.2019.01.013
|View full text |Cite
|
Sign up to set email alerts
|

Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 31 publications
1
11
0
Order By: Relevance
“…Disorders of lipid metabolism such as glutaric aciduria type IIC and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency ( 13 ) or disorders of organic acid metabolism such as lysinuric protein intolerance (LPI) ( 19 , 20 , 35 ), methylmalonic acidemia ( 17 ), propionic acidemia ( 17 , 18 ) may be complicated by HLH. There are many other rare IEMs complicated by HLH that are also reported such as biotinidase deficiency ( 12 ), hepatolenticular degeneration ( 33 ), mevalonate kinase deficiency ( 30 , 31 ), pyrimidine deficiency ( 32 ), disorder of glycogen metabolism ( 14 , 15 ), prolidase deficiency ( 16 ) and cobalamin C disease ( 34 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Disorders of lipid metabolism such as glutaric aciduria type IIC and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency ( 13 ) or disorders of organic acid metabolism such as lysinuric protein intolerance (LPI) ( 19 , 20 , 35 ), methylmalonic acidemia ( 17 ), propionic acidemia ( 17 , 18 ) may be complicated by HLH. There are many other rare IEMs complicated by HLH that are also reported such as biotinidase deficiency ( 12 ), hepatolenticular degeneration ( 33 ), mevalonate kinase deficiency ( 30 , 31 ), pyrimidine deficiency ( 32 ), disorder of glycogen metabolism ( 14 , 15 ), prolidase deficiency ( 16 ) and cobalamin C disease ( 34 ).…”
Section: Discussionmentioning
confidence: 99%
“…Some patients may develop metabolic encephalopathy ( 17 , 18 , 30 ), and some patients may have severe gastrointestinal symptoms ( 20 , 26 , 27 ). Metabolic acidosis is also a relatively common clinical manifestation in IEM complicated by HLH ( 17 , 32 ). Treatments may be variable and may include IVIG, etoposide, cyclosporine, plasma exchange and hematopoietic cell transplantation (table 2).…”
Section: Discussionmentioning
confidence: 99%
“…The mixed phenotype of the two coexisting single gene defects might have been the main reason for the rapid deterioration of the condition in the patient, leading to multiple organ failure and early death. 11 …”
Section: Literature Reviewmentioning
confidence: 99%
“…With the advent of HTS, it had been recognized that phenotypic variability or atypical presentation of a disease may be due to two or more genetic conditions with overlapping (blended) or discrete (composite) manifestations [25,26,27]. Newly discovered genetic conditions may also co-occur with another genetic condition(s) [28,29] (e.g., NPL and GJB2 composite effects in a patient with sialuria, exercise intolerance/muscle wasting, cardiac symptoms, and deafness) [28]. Thus, considering multiple diagnoses in a patient is important in presumed monogenic disorders, especially the ones with atypical ‘ultra’ rare phenotypes [30] and/or substantial phenotypic variability [31] before a conclusion on expanded clinical presentation of a monogenic disease is made.…”
Section: Complexity Of Rare Diseasesmentioning
confidence: 99%